Cover Image
市場調查報告書

流式細胞儀:醫療設備的開發平台評估

Flow Cytometers - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 356285
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
流式細胞儀:醫療設備的開發平台評估 Flow Cytometers - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年04月03日 內容資訊: 英文 48 Pages
簡介

本報告提供全球流式細胞儀市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (授權合約·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 流式細胞儀概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:估計各認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 流式細胞儀的企業:各臨床實驗階段的開發中產品
  • 流式細胞儀:各臨床實驗階段的開發中產品

第5章 流式細胞儀市場:企業·產品概要

  • Becton, Dickinson and Company
    • 開發中產品及進行中的臨床實驗概要
  • Boston University
  • Cytognos, S.L.
  • LeukoDx Ltd
  • NanoCellect Biomedical, Inc.
  • Sandia Electro-Optics Corporation
  • University of California, Los Angeles
  • University of Colorado
  • University of New Mexico
  • VeraPulse LLC

第6章 流式細胞儀市場:目前的趨勢 (全19件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Flow Cytometers - Medical Devices Pipeline Assessment, 2017" provides an overview of Flow Cytometers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Flow Cytometers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Flow Cytometers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Flow Cytometers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Flow Cytometers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Flow Cytometers Overview 5

3 Products under Development 6

  • 3.1 Flow Cytometers - Pipeline Products by Stage of Development 6
  • 3.2 Flow Cytometers - Pipeline Products by Territory 7
  • 3.3 Flow Cytometers - Pipeline Products by Regulatory Path 8
  • 3.4 Flow Cytometers - Pipeline Products by Estimated Approval Date 9

4 Flow Cytometers - Pipeline Products under Development by Companies 10

  • 4.1 Flow Cytometers Companies - Pipeline Products by Stage of Development 10
  • 4.2 Flow Cytometers - Pipeline Products by Stage of Development 11

5 Flow Cytometers Companies and Product Overview 12

  • 5.1 Acousys Biodevices Inc Company Overview 12
    • 5.1.1 Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • 5.2 Becton Dickinson and Co Company Overview 13
    • 5.2.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.3 Boston University Company Overview 15
    • 5.3.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.4 Eta Diagnostics Inc Company Overview 16
    • 5.4.1 Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.5 LeukoDx Ltd Company Overview 17
    • 5.5.1 LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.6 NanoCellect Biomedical, Inc. Company Overview 18
    • 5.6.1 NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.7 University of California Los Angeles Company Overview 21
    • 5.7.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.8 University of Colorado Company Overview 22
    • 5.8.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.9 University of New Mexico Company Overview 23
    • 5.9.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.10 VeraPulse LLC Company Overview 24
    • 5.10.1 VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 24

6 Flow Cytometers- Recent Developments 25

  • 6.1 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 25
  • 6.2 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 25
  • 6.3 Mar 15, 2017: Cytek Biosciences Introduces New Compact Flow Cytometry System 25
  • 6.4 Jan 24, 2017: Novacyt Revenues Full Year 2016 26
  • 6.5 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 27
  • 6.6 Dec 01, 2016: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 28
  • 6.7 Dec 01, 2016: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 29
  • 6.8 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 29
  • 6.9 Oct 27, 2016: Novacyt Half Year 2016 Results 31
  • 6.10 Sep 12, 2016: Sysmex Europe rolls out new flow cytometry portfolio 33
  • 6.11 Sep 05, 2016: Novacyt provides an R&D update on its initial molecular products pipeline 33
  • 6.12 Aug 26, 2016: NanoCellect Biomedical Raises USD0.5 Million in Venture Financing 35
  • 6.13 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 35
  • 6.14 Aug 03, 2016: Ornim Raises USD20 Million in Series C Venture Financing 37
  • 6.15 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 37
  • 6.16 Jul 20, 2016: Novacyt Half Year 2016 Revenues 37
  • 6.17 Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts 38
  • 6.18 Jun 28, 2016: Sartorius Acquires IntelliCyt for USD90 Million 39
  • 6.19 Jun 13, 2016: Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 39
  • 6.20 Jun 09, 2016: Cyprotex Purchase New IntelliCyt iQue Screener for Expansion of Cell-Based Services 39
  • 6.21 Jun 07, 2016: Sysmex America to Exhibit Flow Cytometry Products at CYTO 2016 39
  • 6.22 Jun 03, 2016: Acousys Biodevices Announces Proof-of-Concept Data Demonstrating Photoacoustic Technology Platform Accurately Detects Circulating Tumor Cells in Stage III Melanoma Patients Accepted for Poster Presentation at ASCO Meeting 40
  • 6.23 May 26, 2016: BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody System 41
  • 6.24 May 11, 2016: Merck Expands Popular Line of Guava Flow Cytometers 41
  • 6.25 May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter 42

7 Appendix 45

  • 7.1 Methodology 45
  • 7.2 About GlobalData 48
  • 7.3 Contact Us 48
  • 7.4 Disclaimer 48

List of Tables

1.1 List of Tables

  • Table 1: Flow Cytometers - Pipeline Products by Stage of Development 6
  • Table 2: Flow Cytometers - Pipeline Products by Territory 7
  • Table 3: Flow Cytometers - Pipeline Products by Regulatory Path 8
  • Table 4: Flow Cytometers - Pipeline Products by Estimated Approval Date 9
  • Table 5: Flow Cytometers Companies - Pipeline Products by Stage of Development 10
  • Table 6: Flow Cytometers - Pipeline Products by Stage of Development 11
  • Table 7: Acousys Biodevices Inc Pipeline Products & Ongoing Clinical Trials Overview 12
  • Table 8: Acousys Photoacoustic Flow Cytometer - Product Status 12
  • Table 9: Acousys Photoacoustic Flow Cytometer - Product Description 12
  • Table 10: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 11: BD FACSClearCount CD4 Analyzer - Product Status 13
  • Table 12: BD FACSClearCount CD4 Analyzer - Product Description 13
  • Table 13: Sepsis Flow Cytometric Diagnostic System - Product Status 14
  • Table 14: Sepsis Flow Cytometric Diagnostic System - Product Description 14
  • Table 15: Boston University Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 16: Parallel Microfluidic Flow Cytometer - Product Status 15
  • Table 17: Parallel Microfluidic Flow Cytometer - Product Description 15
  • Table 18: Eta Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 19: Parallel Flow Cytometer - Product Status 16
  • Table 20: Parallel Flow Cytometer - Product Description 16
  • Table 21: LeukoDx Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 22: Micro-Flowcytometer System - Product Status 17
  • Table 23: Micro-Flowcytometer System - Product Description 17
  • Table 24: NanoCellect Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 25: FlowNostic System - Product Status 18
  • Table 26: FlowNostic System - Product Description 18
  • Table 27: Lab-On-A-Chip Flow Cytometer - COST Coding - Product Status 19
  • Table 28: Lab-On-A-Chip Flow Cytometer - COST Coding - Product Description 19
  • Table 29: OncoSorter - Product Status 19
  • Table 30: OncoSorter - Product Description 20
  • Table 31: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 32: Microfluidic Image Cytometry Device - Product Status 21
  • Table 33: Microfluidic Image Cytometry Device - Product Description 21
  • Table 34: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 35: Flow Cytometry Device - Product Status 22
  • Table 36: Flow Cytometry Device - Product Description 22
  • Table 37: University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 38: Magnecytometer - Product Status 23
  • Table 39: Magnecytometer - Product Description 23
  • Table 40: VeraPulse LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 41: Photoacoustic Flow Cytometry Device - Product Status 24
  • Table 42: Photoacoustic Flow Cytometry Device - Product Description 24
  • Table 43: Glossary 47

List of Figures

1.2 List of Figures

  • Figure 1: Flow Cytometers - Pipeline Products by Stage of Development 6
  • Figure 2: Flow Cytometers - Pipeline Products by Territory 7
  • Figure 3: Flow Cytometers - Pipeline Products by Regulatory Path 8
  • Figure 4: Flow Cytometers - Pipeline Products by Estimated Approval Date 9
Back to Top